Heron Therapeutics (HRTX) Non-cash Items (2011 - 2025)

Heron Therapeutics has reported Non-cash Items for 15 years, with the latest figure at $11.8 million in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items rose 687.13% year-over-year to $11.8 million; the trailing twelve-month figure through Dec 2025 stood at $11.8 million (up 687.13% YoY), and the FY2025 full-year result was $11.8 million, up 687.13% from the prior year.
• Non-cash Items for Q4 2025 stood at $11.8 million, up from $1.5 million in the prior quarter.
• The five-year high for Non-cash Items was $13.6 million in Q4 2022, with the low at $1.5 million in Q4 2024.
• Historically, Non-cash Items has averaged $6.3 million across 5 years, with a median of $2.8 million in 2023.
• Annual changes were most pronounced in 2021 — Non-cash Items tumbled 83.39% — and 2022, when it soared 702.94%.
• Heron Therapeutics' Non-cash Items stood at $1.7 million in 2021, then soared by 702.94% to $13.6 million in 2022, then sank by 79.49% to $2.8 million in 2023, then slumped by 46.43% to $1.5 million in 2024, then jumped by 687.13% to $11.8 million in 2025.
• The last three Non-cash Items figures came in at $11.8 million (Q4 2025), $1.5 million (Q4 2024), and $2.8 million (Q4 2023), per Business Quant data.